Source: MarketScreener

PQ Bypass: PQ Bypass : Completes Enrollment in DETOUR2 Percutaneous Femoral-Popliteal Bypass Pivotal Study for Patients With Complex Peripheral Arterial Disease

(marketscreener.com) FDA-designated Breakthrough Device now one step closer to PMA submissionhttps://www.marketscreener.com/news/latest/PQ-Bypass-Completes-Enrollment-in-DETOUR2-Percutaneous-Femoral-Popliteal-Bypass-Pivotal-Study-for--31491814/?utm_medium=RSS&utm_content=20201006

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Richard Ferrari's photo - Chairman & CEO of PQ Bypass

Chairman & CEO

Richard Ferrari

CEO Approval Rating

78/100

Read more